Acadia Pharmaceuticals Inc financial data

Symbol
ACAD on Nasdaq
Location
12830 El Camino Real, Suite 400, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278 % +25.3%
Quick Ratio 29.7 % +34.4%
Debt-to-equity 50.6 % -33.1%
Return On Equity 32.3 % +24.9%
Return On Assets 21.4 % +45.7%
Operating Margin -10.1 % +76.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 169M shares +1.68%
Common Stock, Shares, Outstanding 169M shares +1.68%
Entity Public Float 2B USD -31%
Common Stock, Value, Issued 16K USD 0%
Weighted Average Number of Shares Outstanding, Basic 169M shares +1.72%
Weighted Average Number of Shares Outstanding, Diluted 171M shares +2.69%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 726M USD +40.4%
Revenue from Contract with Customer, Excluding Assessed Tax 1.05B USD +12.7%
Research and Development Expense 345M USD +28%
Costs and Expenses 806M USD -1.32%
Operating Income (Loss) 241M USD +115%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 274M USD +100%
Income Tax Expense (Benefit) 12.5M USD +52.6%
Net Income (Loss) Attributable to Parent 261M USD +103%
Earnings Per Share, Basic 1 USD/shares +101%
Earnings Per Share, Diluted 1 USD/shares +98.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 258M USD +66.3%
Accounts Receivable, after Allowance for Credit Loss, Current 116M USD +18%
Inventory, Net 106M USD +22.2%
Assets, Current 1.08B USD +36.6%
Property, Plant and Equipment, Net 3.71M USD -7.02%
Operating Lease, Right-of-Use Asset 49.7M USD +12.2%
Other Assets, Noncurrent 2.99M USD +734%
Assets 1.33B USD +36.2%
Accounts Payable, Current 21.7M USD +14%
Employee-related Liabilities, Current 37.8M USD +2.14%
Accrued Liabilities, Current 335M USD +3.07%
Liabilities, Current 357M USD +3.68%
Deferred Income Tax Liabilities, Net 11.4M USD -7.83%
Operating Lease, Liability, Noncurrent 43M USD +6.45%
Other Liabilities, Noncurrent 13.9M USD -9.35%
Liabilities 413M USD +3.46%
Accumulated Other Comprehensive Income (Loss), Net of Tax 989K USD +15.3%
Retained Earnings (Accumulated Deficit) -2.09B USD +11.1%
Stockholders' Equity Attributable to Parent 917M USD +58.9%
Liabilities and Equity 1.33B USD +36.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 20.3M USD -30.1%
Net Cash Provided by (Used in) Financing Activities 1.84M USD +76.2%
Net Cash Provided by (Used in) Investing Activities -124M USD -784%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 169M shares +1.68%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -102M USD -733%
Deferred Tax Assets, Valuation Allowance 455M USD -5.63%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 466M USD -5.68%
Operating Lease, Liability 54.8M USD +11%
Depreciation 229K USD -5.37%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 261M USD +101%
Lessee, Operating Lease, Liability, to be Paid 61.9M USD +9.74%
Property, Plant and Equipment, Gross 14.4M USD +1.86%
Operating Lease, Liability, Current 11.8M USD +31.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11.9M USD +49.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 11.9M USD +35.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +23.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.13M USD +0.85%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.4M USD +40.7%
Deferred Tax Assets, Operating Loss Carryforwards 117M USD -21.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 38.4M USD +3.4%
Lessee, Operating Lease, Liability, to be Paid, Year Four 10.9M USD +31.2%
Operating Lease, Payments 11.5M USD +13.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 2.72M USD -48.5%
Deferred Tax Assets, Net of Valuation Allowance 8.7M USD +27.9%
Share-based Payment Arrangement, Expense 49.4M USD -33.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%